BAC BV (Leiden, The Netherlands) and GE Healthcare (Wisconsin, USA) have announced receipt of the ‘Collaboration of the Decade’ award at the BioProcess International Awards 2012. The award has been given in recognition of the collaboration between the two companies to develop innovative purification media for the production of novel biopharmaceuticals. With the increasing demand for biopharmaceuticals (resultant of an ageing population, rising obesity and global vaccine development), the demand for purification methods of higher efficiency has increased the importance of this collaboration since its formation.
The collaboration was formed in 2006, and the two companies have worked closely together to improve the efficiency of biopharmaceutical purification, specifically for use in the manufacture of antibodies, coagulation factors, biosimilars and gene therapy vectors.
Laurens Sierkstra, CEO of BAC, said: “We are delighted to see our joint efforts to enable the development of the latest biotherapeutics recognized by those in the industry. Our on-going collaboration with GE Healthcare has been highly productive and responsive to the needs of end-users.” Commenting on the award, Dr Nigel Darby, Vice President of BioTechnologies, GE Healthcare Life Sciences, added, “Collaborations between companies with complementary technologies and expertise are vital in making the advances that will help us tackle global challenges such as the increasing burden of disease and cost of healthcare. With global demand for cost-effective biotherapeutics set to rise, collaborations like ours that deliver innovative supporting technologies will play an increasingly significant role.”
For more information please visit: